Navigation Links
Northwest Biotherapeutics Appoints Pharma Industry Veteran As CEO Of German Subsidiary
Date:9/18/2012

BETHESDA, Md., Sept. 18, 2012 /PRNewswire/ -- Northwest Biotherapeutics (OTC.BB: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for cancer, announced today that it has appointed former pharmaceutical industry executive Dr. Gunter Rosskamp as the CEO of the Company's German subsidiary, Northwest Biotherapeutics, Gmbh. 

(Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO)

Dr. Rosskamp brings extensive experience as a senior manager in the pharmaceutical sector.  He previously served as Head of Central Nervous System (CNS) therapeutics at Schering AG (now part of Bayer AG) with responsibility for research and development, and global marketing and sales, of CNS products.  This included such drugs as Dopergin (for Parkinson's disease) and Noctamide (a sleeping aid).

Dr. Rosskamp also served as Project Leader for the development and registration (product approval) of the blockbuster drug, Betaseron (for multiple sclerosis), in the European Union.

He subsequently served as Head of Strategic Business Development at Schering AG reporting directly to the Board and determining suitable opportunities in existing franchise areas of the Company, such as hormone products and diagnostics, and new franchise areas such CNS therapeutics and cardiology. 

Dr. Rosskamp also served as Vice President of Life Sciences and Chemicals at the German Industrial Investment Council (IIC).  In that role, he developed a broad network throughout the global pharmaceutical and life sciences industry, including in the US and Asia as well as in Europe.

Dr. Rosskamp served as CEO of three biotech companies, including a company developing treatments for inflammatory and immune disorders, and two companies developing cell therapy products.  Dr. Rosskamp's experience with clinical trials and regulatory requ
'/>"/>

SOURCE Northwest Biotherapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Northwest Bio Receives Regulatory Approval To Proceed With Its Phase III Trial In The UK
2. Northwestern University Joins VIVO Network with Elseviers SciVal Experts
3. Chicago Celebrates First Informatics Week, Co-Chaired by Intelligent Medical Objects and Northwestern University
4. Northwest Bio and Fraunhofer IZI Announce Milestones Reached
5. Northwest Bio Reaffirms Its Freedom to Operate; Refutes Other Parties Misleading Patent Assertions
6. Northwest Bio Implements Major Balance Sheet Clean-Up
7. BioSpace Spotlights Northwests Life Science Community
8. Healthpoint Biotherapeutics To Create State-of-the-Art Cell Sciences Manufacturing Facility
9. Oxford BioTherapeutics Appoints C. Glenn Begley as a Senior Clinical Advisor and Non-executive Director
10. Healthpoint Biotherapeutics to Present at 30th Annual J.P. Morgan Healthcare Conference
11. Aushon BioSystems Appoints Martin Verhoef Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)...  Neogen Corporation (NASDAQ: NEOG ) announced today ... plan in accordance with Securities and Exchange Commission rule ... Neogen Corporation, is a minority owner of this entity ... Herbert does not have control of this entity, ... only for a portion of the shares owned by ...
(Date:3/27/2015)... 27, 2015  CASI Pharmaceuticals, Inc. (Nasdaq: CASI ... and commercialization of innovative therapeutics addressing cancer and other ... commercial focus on China , today ... ended December 31, 2014.  The Company ... per share, for the three months ended December 31, ...
(Date:3/26/2015)... March 26, 2015 The Market Element ... a strategic alliance with Designing Gig LLC to provide ... , “Forging this alliance with Designing Gig ... we can extend a comprehensive, end-to-end, digital solution for ... and execution,” said Chuck Miller, president of The Market ...
(Date:3/26/2015)... March 26, 2015 ReliantHeart, Inc., an ... Transonic, a supplier of precision transit-time flow measurement solutions, ... greatly improve the efficiency of the HeartAssist5® ... patients to experience greater mobility and peace of mind. ... miniature flow board, will draw 1/6th of the power ...
Breaking Biology Technology:Neogen CEO adopts 10b5-1 Trading Plan 2CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 2CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 3CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 4CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 5CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 6The Market Element LLC and Designing Gig LLC Form Strategic Alliance 2LVAD patients to have greater mobility and peace of mind through Transonic and ReliantHeart’s True Flow collaboration for the HeartAssist5® 2LVAD patients to have greater mobility and peace of mind through Transonic and ReliantHeart’s True Flow collaboration for the HeartAssist5® 3
... designed to help consulting engineers and other ... GROVE, Ill., April 8 Siemens Building ... Science Solutions Design Guide written expressly for ... looking to design and specify effective and ...
... Kiadis,Pharma reported preliminary clinical data on ATIR(TM) ... Data was presented by the,company,s principal investigator ... Symposium at the Annual European Bone Marrow ... March 30, 2009. Only the 6,highest ranked ...
... Micromet, Inc. (Nasdaq: MITI ), a ... treatment of cancer, inflammation and autoimmune diseases, today ... Journal of Immunotherapy (1) demonstrating the potent anti-tumor ... antigen (CEA) and to CD3 on T cells. ...
Cached Biology Technology:Siemens Offers Life Science Solutions Design Guide for Consulting Engineers 2Kiadis Pharma Reports ATIR(TM) Clinical Data, Further Supporting its Potential in Mismatched Bone Marrow Transplantations 2Pre-Clinical Data on CEA-specific BiTE Antibody Published in Journal of Immunotherapy Demonstrate Potent Control of Tumor Growth 2Pre-Clinical Data on CEA-specific BiTE Antibody Published in Journal of Immunotherapy Demonstrate Potent Control of Tumor Growth 3Pre-Clinical Data on CEA-specific BiTE Antibody Published in Journal of Immunotherapy Demonstrate Potent Control of Tumor Growth 4
(Date:3/17/2015)...  MecklerMedia Corporation (OTCQX: MECK) announced its ... ever held in New York City ... 2015 at the Javits Convention Center. ... Acorn Product Development; Axis NJ; c-Link Systems; CoroWare; ... NewBotic Corporation; Neya Systems LLC; Reliabotics; RoboKind; RocketFarm ...
(Date:3/12/2015)... MOUNTAIN VIEW, Calif. , March 12, 2015 ... EDTLOCATION:Online, with Complimentary Registration here: http://bit.ly/1G7Os0L . ... Program Manager Aravind SeshagiriPhoto - http://photos.prnewswire.com/prnh/20150311/181111 ... future in order to compete in several different ... the market is currently witnessing an uptrend. ...
(Date:3/10/2015)... --  Tute Genomics , pioneer in affordable, accurate and ... company PrimBio Research Institute to be its ... interpretation. PrimBio, a certified Life Technologies Ampliseq ... to support the work of experts on the front ... of exome sequencing services: 1) Targeted Exome and 2) ...
Breaking Biology News(10 mins):MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 3PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 2PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 3
... about selective serotonin reuptake inhibitors (SSRIs) suggests that these ... like depression and anxiety, have multiple effects on our ... 2010 issue of GENETICS ( http://www.genetics.org ), ... or pathways affected by SSRIs. Such secondary pathways could ...
... at the Buck Institute for Age Research have successfully ... rodents afflicted with Parkinson,s Disease (PD). The research, ... had previously developed, can be used to manufacture the ... paves the way for the use of iPSC,s in ...
... is now clear that RNA plays a major role in ... while also serving as an important tool in functional genomics. ... Review series is providing RNA experts and researchers not only ... also a framework to generate new insights and applications. ...
Cached Biology News:SSRIs may pack more punch at the cellular level than believed 2Scientists successfully use human induced pluripotent stem cells to treat Parkinson's in rodents 2
... is used for single-color real-time detection using ... JOE fluorophores and features a real-time PCR ... from 96 wells, a gene expression macro ... The system includes the optical module and ...
... , CapSure HS and CapSure Macro LCM ... of populations of pure cells from tissue ... Microdissection., Ensure the Integrity of Microdissected ... CapSure LCM Caps have a patented transfer ...
... new MyiQ real-time PCR detection system offers ... common green fluorescent dyes such as FAM ... directly with the iCycler thermal cycler, offering ... Peltier-effect driven performance. The MyiQ real-time PCR ...
Opticon continuous fluorescence detector; includes optical base, analysis software, computer and monitor (this is an accessory for the DNA Engine thermal cyclers which must be ordered seperately)...
Biology Products: